HI
DMRA

Harbour Investments’s Damora Therapeutics DMRA Stock Holding History

Harbour Investments’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04K Hold
40
– – ﹤0.01% 4205
2026
Q1 		$1.04K Buy
+40
New +$1.03K ﹤0.01% 4092
2024
Q4 		– Sell
-8
Closed -$97 – 3529
2024
Q3 		$97 Hold
8
– – ﹤0.01% 3313
2024
Q2 		$95 Hold
8
– – ﹤0.01% 3209
2024
Q1 		$156 Buy
+8
New +$142 ﹤0.01% 3129
2021
Q4 		– Sell
-12
Closed -$1K – 3051
2021
Q3 		$1K Hold
12
– – ﹤0.01% 3508
2021
Q2 		$2K Buy
12
+8
+200% +$1.09K ﹤0.01% 3376
2021
Q1 		$1K Buy
+4
New +$1.09K ﹤0.01% 3386

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Harbour Investments's DMRA Position: Q2 2026 in Review

Harbour Investments held its Damora Therapeutics (DMRA) position steady in Q2 2026 at 40 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #4205.

Harbour Investments first reported a position in DMRA in Q1 2021 and has held it in 8 quarters since. The position peaked at $2K in Q2 2021. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • Harbour Investments held 40 shares of Damora Therapeutics worth $1.04K as of Q2 2026.
  • Harbour Investments left its Damora Therapeutics share count unchanged in Q2 2026.
  • Damora Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4205 holding.
  • Harbour Investments first reported a position in Damora Therapeutics in Q1 2021 and has held it in 8 quarters since.
  • Harbour Investments's Damora Therapeutics position peaked at $2K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.